BioSpace News Archive

Genetown

Myomo Closes $3M Term Loan

Proceeds from Non-Dilutive Financing to be Used to Achieve Near-Term Milestones

October 23, 2019
·
4 min read
Business

McKesson Declares Quarterly Dividend October 23, 2019

The dividend will be payable on January 2, 2020, to stockholders of record on December 2, 2019.

October 23, 2019
·
1 min read
Biotech Bay

Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment Center

Varian proton therapy systems to now be installed in two Penn Medicine centers

October 23, 2019
·
2 min read
Business

bluebird bio Announces Transition of Chief Strategy Officer Jeffrey T. Walsh

Jeffrey T. Walsh, chief strategy officer, has decided to transition from his current role effective January 6, 2020.

October 23, 2019
·
4 min read
Biotech Beach

Mirati Therapeutics Announces Presentation Of Interim Phase 2 Sitravatinib Data In Urothelial Carcinoma And Oral Cavity Squamous Cell Carcinoma At The SITC 34th Annual Meeting

Company will have two presentations at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting on November 6-10, 2019 at the Gaylord National Convention Center in National Harbor, MD.

October 23, 2019
·
5 min read
Business

TherapeuticsMD Announces Proposed Underwritten Public Offering of 22 Million Shares of Common Stock

The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

October 23, 2019
·
4 min read
Business

Study Investigates Effects of Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, on Postoperative Anemia and Inappropriate Blood Transfusion in Patients Undergoing Hip and Knee Surgery

Masimo announced the findings of an abstract recently presented at the American Society of Anesthesiologists 2019 Annual Meeting.

October 23, 2019
·
8 min read
Deals

EXMceuticals inc. applies for a for a voluntary management cease trade order

EXMceuticals Inc. announces that it has applied for a voluntary management cease trade order in accordance with National Policy 12-203 due to it not being able to file its annual financial statements and MD&A for the year ended June 30, 2019 on SEDAR within 120 days of its financial year-end..

October 23, 2019
·
1 min read
Business

Puma Biotechnology to Host Conference Call to Discuss 2019 Third Quarter Financial Results

Puma Biotechnology, Inc., a biopharmaceutical company, will host a conference call at 1:30 p.m. PST/4:30 p.m. EST on Wednesday, November 6, 2019 following release of its third quarter 2019 financial results..

October 23, 2019
·
2 min read
Deals

ICON’s Acquisition of Symphony Clinical Research

Acquisition enhances ICON’s ability to offer customers hybrid trial solutions and site support services

October 23, 2019
·
4 min read